(Q43145175)

14 November 2017

title

Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study (English)

1 reference

14 November 2017

1 reference

1 reference

Arnim Quante

1

1 reference

14 November 2017

Sara Zeugmann

2

1 reference

14 November 2017

Alexander Luborzewski

3

1 reference

14 November 2017

Nicole Schommer

4

1 reference

14 November 2017

Jens Langosch

5

1 reference

14 November 2017

Christoph Born

6

1 reference

14 November 2017

Ion Anghelescu

7

1 reference

14 November 2017

Juergen Wolf

8

1 reference

14 November 2017

publication date

1 March 2010

1 reference

14 November 2017

published in

Human Psychopharmacology

1 reference

14 November 2017

volume

25

1 reference

14 November 2017

issue

2

1 reference

14 November 2017

page(s)

126-132

1 reference

An Inventory for Measuring Depression

14 November 2017

cites work

1 reference

Historical perspectives and natural history of bipolar disorder

21 January 2018

1 reference

7 January 2021

A rating scale for drug-induced akathisia

1 reference

7 January 2021

Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists

1 reference

7 January 2021

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

1 reference

7 January 2021

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

7 January 2021

Antidepressant-associated switches from depression to mania in severe bipolar disorder

1 reference

7 January 2021

A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression

1 reference

7 January 2021

1 reference

7 January 2021

Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review

1 reference

7 January 2021

Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis

1 reference

7 January 2021

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

1 reference

7 January 2021

A rating scale for depression

1 reference

7 January 2021

Factors that affect adherence to bipolar disorder treatments: a stated-preference approach

1 reference

7 January 2021

Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.

1 reference

7 January 2021

Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia

1 reference

7 January 2021

Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.

1 reference

7 January 2021

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

1 reference

7 January 2021

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study

1 reference

7 January 2021

Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial

1 reference

7 January 2021

Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?

1 reference

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

7 January 2021

Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.

1 reference

7 January 2021

Augmentation of antidepressants with atypical antipsychotics: a review of the current literature

1 reference

7 January 2021

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

1 reference

7 January 2021

The treatment of bipolar depression

1 reference

7 January 2021

Effectiveness of adjunctive antidepressant treatment for bipolar depression

1 reference

7 January 2021

Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study

1 reference

7 January 2021

Mortality in affective disorder

1 reference

7 January 2021

A novel augmentation strategy for treating resistant major depression

1 reference

7 January 2021

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

1 reference

7 January 2021

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies

1 reference

7 January 2021

Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.

1 reference

7 January 2021

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

7 January 2021

Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use

1 reference

7 January 2021

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

1 reference

7 January 2021

A rating scale for mania: reliability, validity and sensitivity

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1096

1 reference

14 November 2017

1 reference